Navigation Links
NewCardio Announces Financial Results for Its 2010 Third Quarter
Date:11/15/2010

gnated; 2,920 and -0- shares issued and outstanding as of September 30, 2010 and December 31, 2009, respectively

3

-Preferred stock Series D, $0.001 par value; 1,000 shares designated; no shares issued and outstanding as of September 30, 2010 and December 31, 2009

-

-Common stock, $0.001 par value, 500,000,000 and 99,000,000 shares authorized as of September 30, 2010 and December 31, 2009, respectively; 29,871,857 and 24,290,279 shares issued and outstanding as of September 30, 2010 and December 31, 2009, respectively

29,872

24,290Stock subscription

500,000

-Additional paid in capital

37,371,015

29,432,680Deficit accumulated during development stage

(39,215,289)

(30,930,360)  Total stockholders' deficit

(1,314,387)

(1,473,374)$
3,852,512

$
2,301,318NEWCARDIO, INC

(a development stage company)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSFrom September 7, 2004Three months ended
September 30,

Nine months ended
September 30,

(date of inception) through2010

2009

2010

2009

September 30, 2010Revenue

$99,210

$ -

$169,328

$
-

$
9,328Cost of sales

37,937

-

84,468

-

84,468Gross (loss) profit

61,273

-

84,860

-

84,860Operating expenses:Selling, general and administrative

1,185,170

1,538,141

4,732,292

4,821,003

16,296,612Depreciation

20,446

17,941

59,191

41,249

138,232Research and development

748,401

796,168

2,674,089

2,338,589

9,007,193 Total operating expenses

1,954,017

2,352,250

7,465,572

7,200,841

25,442,037Net loss from operations

(1,892,744)

(2,352,250)

(7,380,712)

(7,200,841)

(25,357,177)Other income (expense)
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NewCardio Announces Positive Results From Third Clinical Validation Study
2. Vincent W. Renz Joins NewCardio as President
3. NewCardio Leadership to Present Two Abstracts at ISCE Conference
4. NewCardio Announces Master Services Agreement With Dedicated Phase I
5. NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit
6. NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress
7. NewCardio CEO Increases Equity Position
8. NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded Testing Dataset
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 Securities lawyers at Dunnam & ... Ltd. (NASDAQ: SLXP ) in connection with ... investors are encouraged to contact attorney Hamilton Lindley by ... focuses upon the shareholder value of the transaction. Under ... only $158.00 per share in cash. At least one ...
(Date:2/27/2015)... , February 27, 2015 Report ... study showing you trends, R&D progress, and predicted revenues ... heading? What are the commercial prospects for this market ... potential revenues and other trends to 2025, discussing data, ... lets you assess regenerative medicine : cell-based therapies ...
(Date:2/27/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, announced today that Keith ... present live at VirtualInvestorConferences.com on March 5th. ... for this Company update," said Mr. Murphy. "We ... of the exVive3D Liver, Bioprinted Human Tissue, commercialization ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
(Date:2/27/2015)... 2015 Royal River Natural Foods, a locally-owned ... study that found adults who got the most magnesium were ... compared to those who got the least magnesium, with the ... The report is part of the March 2015 issue of ... Natural Foods publishes free each month for the Freeport community ...
(Date:2/27/2015)... Adding to its rich history ... Advertising & Marketing has added Sedation Systems of ... patented NITROUSEAL® N20 closed mask and breathing circuit ... , Sedation Systems, http://www.sedationsystems.com is dedicated ... level, though it focuses primarily on pediatric patients. ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FACE ... therapies, has announced a unique combination to take ... neck. Ultherapy Décolletage is a new treatment introduced ... noninvasive procedure specifically indicated to improve lines and ... for any person who suffers from the stubborn ...
(Date:2/27/2015)... 2015 The Nashville periodontist ... scholarship for rising freshmen undergraduate students. , The Advanced ... specializing in many periodontal procedures such as dental ... gum disease . In honor of their 25th anniversary, ... eligible rising freshmen undergraduate students. , Students interested ...
(Date:2/27/2015)... Ford, Pennsylvania (PRWEB) February 27, 2015 ... the Spring Breast Augmentation Special at his Chadds Ford, ... 13 through May 1, 2015, and will be priced ... to the latest silicone implants, it will include more ... price and $250 worth of free Dysport. , Space ...
Breaking Medicine News(10 mins):Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3
... nasal spray to quash allergy symptoms may work better ... an "as-needed'', rather than daily basis, the nasal spray ... sneezing and congestion more effectively than the antihistamine loratadine ... fights allergy symptoms by reducing the inflammation that occurs ...
... intravenous magnesium sulfate to standard emergency department migraine ... enhance the effectiveness of treatment.// Dr. Jill Corbo, ... Medicine in the Bronx, New York, note that ... in the treatment of migraine headache and that ...
... to bear an underweight child, but some women may ... susceptibility.// The finding could help medicine better determine the ... they were not recommending at this point that women ... ,"Our data demonstrate that a subgroup of pregnant ...
... that butterbur extract is an effective antihistamine without any ... an active biochemical agent,// otherwise it would not work ... react with other medications. ,It was used ... either butterbur extract tablets or the usually used non-sedating ...
... 40,000 more lives each year worldwide if more people at ... it, doctors said.// An analysis of nearly 300 clinical ... prevent blood clots confirmed that aspirin reduces heart attacks and ... people who could benefit from aspirin and anti-platelet therapy receive ...
... stones, which are often extremely painful to excrete, cost ... lost productivity. While the stones can sometimes be prevented ... the bladder frequently,// medication to reduce the excretion of ... increase cholesterol and can cause bloating and other uncomfortable ...
Cached Medicine News:
... The IMMULITE 1000 immunoassay system features ... reliability, robust hardware and excellent assay ... reagents and accommodates onboard dilutions, positive ... , Worldwide, IMMULITE 1000 (and its ...
... The AIA-1800 is the newest and most ... Inc. The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... 250 is a flexible system ... multiple environments small hospitals, ... and satellite locations. The Vitros ... and can be automated or ...
Medicine Products: